Search results
A Startling New Study Found That 75% of Past COVID Patients May Suffer From This Heart Condition
Parade· 2 days agoA new study of 200 COVID-19 patients between the ages of 18 and 83 revealed that more than 75% of...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 19 hours agoMore choice and tailored vaccine administration According to GlobalData’s pipeline drugs database,...
We May Be One Step Closer To Male Birth Control. We Asked Guys If They'd Use It
HuffPost Life via Yahoo News· 6 hours agoWould you still be willing to take it? No question. Sign me up. I would certainly monitor the side ...
‘I took an oath to do no harm’: The two doctors wrestling over Fauci’s legacy
Washington Post· 5 days agoFour years later, the Republican congressman is still thinking about China’s potential links to ...
4 ways vaccine skeptics mislead you on measles and more
The Columbian· 6 days agoMeasles is on the rise in the United States. In the first quarter of this year, the number of cases...
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 7 days agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Trial of hormonal gel shows promise for male birth control
UPI· 3 days agoA new hormonal gel could one day be a potential form of birth control for men, researchers reported...
Immunotherapy drug may keep colon cancer patients cancer-free after surgery
UPI· 4 days agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more colon...
Opinion | Paxlovid Trial Flops for COVID Pneumonia
MedPage Today· 1 day agoIn 2021, nirmatrelvir/ritonavir clearly decreased hospitalization and death among COVID-19 patients who had high risks of severe disease and who had not...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 7 days agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...